Skip to main content
×
Home

Reasons for measles cases not being vaccinated with MMR: investigation into parents' and carers' views following a large measles outbreak

  • P. McHALE (a1), A. KEENAN (a2) and S. GHEBREHEWET (a2)
Summary
SUMMARY

Uptake rates for the combined measles, mumps and rubella (MMR) vaccine have been below the required 95% in the UK since a retracted and discredited article linking the MMR vaccine with autism and inflammatory bowel disease was released in 1998. This study undertook semi-structured telephone interviews among parents or carers of 47 unvaccinated measles cases who were aged between 13 months and 9 years, during a large measles outbreak in Merseyside. Results showed that concerns over the specific links with autism remain an important cause of refusal to vaccinate, with over half of respondents stating this as a reason. A quarter stated child illness during scheduled vaccination time, while other reasons included general safety concerns and access issues. Over half of respondents felt that more information or a discussion with a health professional would help the decision-making process, while a third stated improved access. There was clear support for vaccination among respondents when asked about current opinions regarding MMR vaccine. The findings support the hypothesis that safety concerns remain a major barrier to MMR vaccination, and also support previous evidence that experience of measles is an important determinant in the decision to vaccinate.

Copyright
Corresponding author
* Author for correspondence: Dr P. McHale, Sefton Council, 6th Floor, Merton House, Stanley Road, Bootle L20 3DL, UK. (Email: pmchale99@gmail.com)
References
Hide All
1. Brown KF, et al. Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review. Vaccine 2010; 28: 42354248.
2. Lamden KH, Gemmell I. General practice factors and MMR vaccine uptake: structure, process and demography. Journal of Public Health 2008; 30: 251257.
3. Public Health England. Contraindications and special considerations: the Green Book, chapter 6, 2013 (https://www.gov.uk/government/publications/contraindications-and-special-considerations-the-green-book-chapter-6). Accessed 17 April 2014.
4. Pearce A, et al. Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study. British Medical Journal 2008; 336: 754757.
5. Public Health England. Highest MMR vaccine coverage in 25 years, 2013 (https://www.gov.uk/government/news/highest-mmr-vaccine-coverage-in-25-years). Accessed 14 June 2014.
6. Wakefield AJ, et al. Retracted: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637641.
7. Friederichs V, Cameron JC, Robertson C. Impact of adverse publicity on MMR vaccine uptake: a population based analysis of vaccine uptake records for one million children, born 1987–2004. Archives of Disease in Childhood 2006; 91: 465468.
8. Chen RT, DeStefano F. Vaccine adverse events: causal or coincidental? Lancet 1998; 351: 611612.
9. Nicoll A, Elliman D, Ross E. MMR vaccination and autism 1998. British Medical Journal 1998; 316: 715716.
10. Bower H. MMR vaccine policy is backed. British Medical Journal 1998; 316: 955.
11. Metcalf J. Is measles infection associated with Crohn's disease? British Medical Journal 1998; 316: 166.
12. Fombonne E. Inflammatory bowel disease and autism. Lancet 1998; 351: 955.
13. Patja A, et al. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatric Infectious Disease Journal 2000; 19: 11271134.
14. Peltola H, et al. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998; 351: 13271328.
15. Kaye JA, Melero-Montes MdM, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. British Medical Journal 2001; 322: 460463.
16. Taylor B, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999; 353: 20262029.
17. Taylor B, et al. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. British Medical Journal 2002; 324: 393396.
18. Vivancos R, et al. An ongoing large outbreak of measles in Merseyside, England, January to June 2012. Eurosurveillance 2012; 17.
19. Alfredsson R, et al. Why do parents hesitate to vaccinate their children against measles, mumps and rubella? Acta Paediatrica 2004; 93: 12321237.
20. Bardenheier B, et al. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis b vaccines by children? Archives of Pediatrics and Adolescent Medicine 2004; 158: 569575.
21. Casiday R, et al. A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine 2006; 24: 177184.
22. Gellatly J, McVittie C, Tiliopoulos N. Predicting parents' decisions on MMR immunisation: a mixed method investigation. Family Practice 2005; 22: 658662.
23. Cassell JA, et al. Is the cultural context of MMR rejection a key to an effective public health discourse? Public Health 2006; 120: 783794.
24. Mills E, et al. Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination. Journal of Clinical Epidemiology 2005; 58: 10811088.
25. Le Menach A, et al. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England. Vaccine 2014; 32: 11471152.
26. Paranthaman K, Bunce A. Opportunistic MMR vaccination for unimmunized children at the time of routine teenage booster vaccination in secondary schools: implications for policy. Epidemiology and Infection 2012; 140: 16121616.
27. Nyhan B, et al. Effective messages in vaccine promotion: a randomized trial. Pediatrics 2014; 133: 835842.
28. Jackson C, et al. Randomised cluster trial to support informed parental decision-making for the MMR vaccine. BMC Public Health 2011; 11: 475.
29. McMurray R, et al. Managing controversy through consultation: a qualitative study of communication and trust around MMR vaccination decisions. British Journal of General Practice 2004; 54: 520525.
30. Brown KF, et al. U.K. parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis. Vaccine 2012; 30: 18551864.
31. Samad L, et al. Incomplete immunisation uptake in infancy: maternal reasons. Vaccine 2006; 24: 68236829.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 55
Total number of PDF views: 279 *
Loading metrics...

Abstract views

Total abstract views: 1505 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 18th November 2017. This data will be updated every 24 hours.